Effect of amiloride on lithium-induced chronic nephropathy. Comparing discontinuation of lithium treatment to adding amiloride while continuing lithium treatment.
This historical record does not confirm current site availability.
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Netherlands
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
This is historical registry information. What is the current study status and protocol?
Things to check before joining
- Recruitment status
- Recruitment unclear
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Parnassia-BAVO groep [...] 1. Parnassia-BAVO groep 2. St. Elisabeth Ziekenhuis 3. University Medical Center Utrecht
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Netherlands
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2008-004746-81
- Official title
Show the full official title
Effect of amiloride on lithium-induced chronic nephropathy. Comparing discontinuation of lithium treatment to adding amiloride while continuing lithium treatment.
Recruitment & locations
Netherlands
Registry details
- Netherlands — Ongoing
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Parnassia-BAVO groep [...] 1. Parnassia-BAVO groep 2. St. Elisabeth Ziekenhuis 3. University Medical Center Utrecht, a hospital or academic medical center.
